Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Depreciation & Amortization (CF): 2012-2025

Historic Depreciation & Amortization (CF) for CorMedix (CRMD) over the last 10 years, with Sep 2025 value amounting to $161,917.

  • CorMedix's Depreciation & Amortization (CF) rose 535.97% to $161,917 in Q3 2025 from the same period last year, while for Sep 2025 it was $464,631, marking a year-over-year increase of 421.63%. This contributed to the annual value of $153,937 for FY2024, which is 117.56% up from last year.
  • CorMedix's Depreciation & Amortization (CF) amounted to $161,917 in Q3 2025, which was up 45.88% from $110,993 recorded in Q2 2025.
  • Over the past 5 years, CorMedix's Depreciation & Amortization (CF) peaked at $161,917 during Q3 2025, and registered a low of $11,994 during Q1 2021.
  • For the 3-year period, CorMedix's Depreciation & Amortization (CF) averaged around $69,213, with its median value being $53,594 (2024).
  • In the last 5 years, CorMedix's Depreciation & Amortization (CF) plummeted by 75.15% in 2021 and then skyrocketed by 535.97% in 2025.
  • Over the past 5 years, CorMedix's Depreciation & Amortization (CF) (Quarterly) stood at $20,047 in 2021, then grew by 12.32% to $22,516 in 2022, then fell by 16.73% to $16,863 in 2023, then climbed by 29.43% to $81,727 in 2024, then surged by 535.97% to $161,917 in 2025.
  • Its last three reported values are $161,917 in Q3 2025, $110,993 for Q2 2025, and $109,994 during Q1 2025.